341 related articles for article (PubMed ID: 19805751)
1. Ductus venosus pulsatility index as an antenatal screening marker for Down's syndrome: use with the Combined and Integrated tests.
Borrell A; Borobio V; Bestwick JP; Wald NJ
J Med Screen; 2009; 16(3):112-8. PubMed ID: 19805751
[TBL] [Abstract][Full Text] [Related]
2. Cross-trimester marker ratios in prenatal screening for Down syndrome.
Wald NJ; Bestwick JP; Morris JK
Prenat Diagn; 2006 Jun; 26(6):514-23. PubMed ID: 16739232
[TBL] [Abstract][Full Text] [Related]
3. Prenatal screening for Down's syndrome using inhibin-A as a serum marker.
Wald NJ; Densem JW; George L; Muttukrishna S; Knight PG
Prenat Diagn; 1996 Feb; 16(2):143-53. PubMed ID: 8650125
[TBL] [Abstract][Full Text] [Related]
4. Multiple-marker screening for Down's syndrome: a method of assessing the statistical robustness of proposed tests.
Morris JK; Bestwick J; Wald NJ
J Med Screen; 2008; 15(2):55-61. PubMed ID: 18573771
[TBL] [Abstract][Full Text] [Related]
5. Improvements in antenatal screening for Down's syndrome.
Wald NJ; Bestwick JP; Huttly WJ
J Med Screen; 2013 Mar; 20(1):7-14. PubMed ID: 23512549
[TBL] [Abstract][Full Text] [Related]
6. Adding ductus venosus blood flow as a categorical variable to the Combined and Integrated tests in Down's syndrome screening.
Wald NJ; Bestwick JP; Borrell A
J Med Screen; 2012 Mar; 19(1):49-50. PubMed ID: 22357351
[TBL] [Abstract][Full Text] [Related]
7. Analysis of three different strategies in prenatal screening for Down's syndrome in twin pregnancies.
Prats P; RodrÃguez I; Comas C; Puerto B
J Matern Fetal Neonatal Med; 2013 Sep; 26(14):1404-9. PubMed ID: 23488563
[TBL] [Abstract][Full Text] [Related]
8. Repeated measures screening for Down's Syndrome.
Wright DE; Bradbury I
BJOG; 2005 Jan; 112(1):80-3. PubMed ID: 15663402
[TBL] [Abstract][Full Text] [Related]
9. Effect on Down syndrome screening performance of adjusting for marker levels in a previous pregnancy.
Wald NJ; Barnes IM; Birger R; Huttly W
Prenat Diagn; 2006 Jun; 26(6):539-44. PubMed ID: 16634123
[TBL] [Abstract][Full Text] [Related]
10. Antenatal screening for Down's syndrome using the Integrated test at two London hospitals.
Wald NJ; Huttly WJ; Murphy KW; Ali K; Bestwick JP; Rodeck CH
J Med Screen; 2009; 16(1):7-10. PubMed ID: 19349524
[TBL] [Abstract][Full Text] [Related]
11. An update on antenatal screening for Down's syndrome and specific implications for assisted reproduction pregnancies.
Weisz B; Rodeck CH
Hum Reprod Update; 2006; 12(5):513-8. PubMed ID: 16672245
[TBL] [Abstract][Full Text] [Related]
12. Experience on triple markers serum screening for Down's syndrome fetus in Hat Yai, Regional Hospital.
Lamlertkittikul S; Chandeying V
J Med Assoc Thai; 2007 Oct; 90(10):1970-6. PubMed ID: 18041410
[TBL] [Abstract][Full Text] [Related]
13. Estimating the risk of Down's syndrome in antenatal screening and the gestation at which this risk applies.
Morris JK; Wald NJ
J Med Screen; 2007; 14(1):5-7. PubMed ID: 17362564
[TBL] [Abstract][Full Text] [Related]
14. Serum müllerian-inhibiting substance in Down's syndrome pregnancies.
Seifer DB; MacLaughlin DT; Cuckle HS
Hum Reprod; 2007 Apr; 22(4):1017-20. PubMed ID: 17218369
[TBL] [Abstract][Full Text] [Related]
15. First trimester Down's syndrome screening marker values and cigarette smoking: new data and a meta-analysis on free beta human chorionic gonadotophin, pregnancy-associated plasma protein-A and nuchal translucency.
Bestwick JP; Huttly WJ; Wald NJ
J Med Screen; 2008; 15(4):204-6. PubMed ID: 19106261
[TBL] [Abstract][Full Text] [Related]
16. Antenatal screening for Down's syndrome with the quadruple test.
Wald NJ; Huttly WJ; Hackshaw AK
Lancet; 2003 Mar; 361(9360):835-6. PubMed ID: 12642052
[TBL] [Abstract][Full Text] [Related]
17. Fetuses with Down's Syndrome detected by prenatal screening are more likely to abort spontaneously than fetuses with Down's Syndrome not detected by prenatal screening.
Leporrier N; Herrou M; Morello R; Leymarie P
BJOG; 2003 Jan; 110(1):18-21. PubMed ID: 12504930
[TBL] [Abstract][Full Text] [Related]
18. Comparing three screening strategies for combining first- and second-trimester Down syndrome markers.
Palomaki GE; Steinort K; Knight GJ; Haddow JE
Obstet Gynecol; 2006 Feb; 107(2 Pt 1):367-75. PubMed ID: 16449126
[TBL] [Abstract][Full Text] [Related]
19. Sequential and contingent prenatal screening for Down syndrome.
Wald NJ; Rudnicka AR; Bestwick JP
Prenat Diagn; 2006 Sep; 26(9):769-77. PubMed ID: 16821246
[TBL] [Abstract][Full Text] [Related]
20. Median parameters for Down's syndrome screening should be calculated using a moving time-window method.
Reynolds TM; Aldis J
Ann Clin Biochem; 2008 Nov; 45(Pt 6):567-70. PubMed ID: 18768535
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
